Security key
03589W102
Annexon, Inc. - Common Stock, par value $0.001 per share (ANNX)
CUSIP: 03589W102
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 46,270,615
- Total 13F value
- $285,949,000
- Share change
- +7,860,954
- Put/Call ratio
- 54%
- SEC-reported price per share
- $6.18
- Number of holders
- 69
- Value change
- +$49,950,788
- Number of buys
- 31
- Number of sells
- 33
- Shares outstanding
- 161,077,278
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
69
Top holders
10
ANNX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Annexon, Inc. SEC filings
Annexon, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03589W102
Recent filing periods:
Ownership snapshot
Top reported holders of ANNX - Annexon, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 2.3%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 2.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
2.3%
EVENTIDE ASSET MANAGEMENT, LLC
2.3%
Redmile Group, LLC
2.2%
Bain Capital Life Sciences Invest...
2%
FEDERATED HERMES, INC.
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
2.3%
|
$14,253,000
3,780,694 shares
|
— | 30 Jun 2022 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
2.3%
|
$13,672,000
3,626,508 shares
|
— | 30 Jun 2022 |
| Redmile Group, LLC |
13F
Company
|
2.2%
|
$13,207,000
3,503,190 shares
|
— | 30 Jun 2022 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
2%
|
$12,221,000
3,241,628 shares
|
— | 30 Jun 2022 |
| FEDERATED HERMES, INC. |
13F
Company
|
1.9%
|
$11,510,000
3,052,960 shares
|
— | 30 Jun 2022 |
| Fairmount Funds Management LLC |
13F
Company
|
1.8%
|
$10,905,000
2,892,600 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
69
Shares
46,270,615
Rows available
69
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
74
Q3 2022 holders
69
Holder diff
-5
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend